SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Briefs

Inside Views

Contribute your views! Submit an Inside Views idea to info [at] ip-watch [dot] ch.

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Call For Transparency In The Trans-Pacific Partnership Negotiation

In this post, three US law professors explain a recent call by over 30 legal scholars for the US Trade Representative to increase transparency for the Trans-Pacific Partnership Agreement intellectual property chapter, and their response to Ambassador Kirk’s response that he is “strongly offended” by the suggestion that the negotiation is not adequately transparent already.





Latest Comments
  • This is a good summary, except just to clarify one... »
  • Ellen 't Hoen will be a hard act to follow. She p... »

  • For IPW Subscribers
    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    Public Health

    20/05/2012: India’s Generics-Big Pharma Battle Drops Drug Prices, Raises Legal Debate
    19/05/2012: Drug Safety Needs Global Cooperation Of Drug Regulators, Officials Say
    18/05/2012: US Licensing Experts: Innovation Is Still Happening, Let’s Help It Along
    16/05/2012: After Sharp Concerns, Cooperation Prevails On UNCTAD’s Mandate For Next Four Years
    11/05/2012: DNDi Backs WHO ‘Neglected Patients’ R&D Treaty
    10/05/2012: New IFPMA-Backed Report On R&D For Diseases In Developing Countries
    08/05/2012: German Ministry Advises Developing Countries Not To Sign ACTA
    03/05/2012: Draft Proposal Calls For Delay Of WHO R&D Treaty Talks
    02/05/2012: Full Agenda For WHO: Reform, R&D Convention, Substandard Medicines, NCDs, Pandemics
    27/04/2012: Confidential Documents Show Tough Staff Choices At Global Fund
    25/04/2012: Book Offers Timely Insights On IP, Drugs And Public Health In Developing Countries
    23/04/2012: Text Of Kenya Judgment On Anti-Counterfeiting Now Available
    21/04/2012: Kenyan High Court’s Overturning Of Anti-Counterfeit Law Hailed
    20/04/2012: The WHO’s Final Sprint Toward An International Convention On R&D
    18/04/2012: Divergences Clarified On Protection Of Traditional Knowledge At WIPO
    16/04/2012: Medicines Patent Pool Director Ellen ‘t Hoen To Leave Next Month
    05/04/2012: After Mayo, Is Patent Law More Restrictive In US Than Europe?
    04/04/2012: ‘Counterfeit’ Dropped From New WHO Protocol On Illicit Tobacco Trade
    04/04/2012: Honduras Files WTO Dispute Case Vs. Australia Over Tobacco IPR
    04/04/2012: Group Says Industry, EPO Finding Loopholes To Patent Seeds, Plants
    02/04/2012: Book Details IP Rights And Development
    02/04/2012: WHO / EU “Bad Medicine” Plans: Flaws, Coordination Gaps
    28/03/2012: Novartis India Challenge Postponed To July
    27/03/2012: US Supreme Court Reverses Myriad Decision Allowing Gene Patents
    23/03/2012: Global Fund Changes Continue As West Africa Team Leader Departs
    22/03/2012: WHO Head Urges Global Support For Australia In Fight Against Tobacco
    21/03/2012: US Supreme Court Narrows Patentable Subject Matter
    21/03/2012: Brazil HIV Drug Patent Ruling Allows Generics, Sends Pipeline Process Into Doubt
    15/03/2012: Take The Brussels University Survey On Beliefs About IP
    14/03/2012: Intérêt de l’entreprise et choix stratégiques : les licences concédées par Gilead au Medicines Patent Pool
    14/03/2012: WIPO To Discuss Role Of Patents In Access To Water
    14/03/2012: Ukraine WTO Trademark Dispute Vs. Australia Tests Public Health Measures
    13/03/2012: WHO Under Siege By Private Sector, Group Asserts
    12/03/2012: India Grants First Compulsory Licence, For Bayer Cancer Drug
    02/03/2012: European Parliament Hears Pitch For ACTA; But Did It Change Minds?
    02/03/2012: Novartis Before India’s Supreme Court: What’s Really At Stake?
    29/02/2012: ACTA Debated At WTO; Petitions And Letters Fly In Brussels
    28/02/2012: Australian Tobacco Law May Head To WTO Dispute As TRIPS Council Meets
    24/02/2012: The Pulse Of IP In International Pharma Today
    17/02/2012: WHO Group Keeps Lid On Bird Flu Lab Results – For Now
    17/02/2012: Public Health In 2012: A Busy Crossroads Of Partnership, Innovation, And Trade
    13/02/2012: Global Fund Communications Director Steps Down
    12/02/2012: US, WIPO Training Programme On IP Rights In Africa Comes Under Fire
    10/02/2012: EU-India Summit Kicks Off Amidst Warnings Of Impact On Medicines Access
    07/02/2012: WHO Group To Consult On Pandemic Flu Framework In Lead-Up To Assembly
    02/02/2012: Another Indian Generics Company Signs With Patent Pool
    31/01/2012: European Commission Orders Italy To Drop Patent Linkage Delaying Generics
    30/01/2012: WHO, Gates, Industry And NGO Leaders Elevate Attention To Neglected Diseases
    28/01/2012: WHO Board Plan For Fake Medicines Mechanism Excludes Trade And IP
    26/01/2012: Officials, Industry Discuss IPR In Relation To Economy And Society